Gene: METTL25
Official Full Name: methyltransferase like 25provided by HGNC
Gene Summary: Predicted to enable methyltransferase activity. Predicted to be involved in methylation. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25108 | METTL25 Knockout cell line (HeLa) | Human | METTL25 | 1:3~1:6 | Negative | Online Inquiry |
KO25109 | METTL25 Knockout cell line (HCT 116) | Human | METTL25 | 1:2~1:4 | Negative | Online Inquiry |
KO25110 | METTL25 Knockout cell line (HEK293) | Human | METTL25 | 1:3~1:6 | Negative | Online Inquiry |
KO25111 | METTL25 Knockout cell line (A549) | Human | METTL25 | 1:3~1:4 | Negative | Online Inquiry |
METTL25 Gene Knockout Cell Lines are engineered cellular models designed to facilitate the study of the METTL25 gene, a critical player in various cellular processes, including RNA methylation and gene expression regulation. These cell lines have undergone targeted gene editing to effectively eliminate METTL25 expression, providing researchers with a robust tool to investigate the gene's role in cellular functions and its implications in health and disease.
The key function of METTL25 Gene Knockout Cell Lines lies in their ability to help elucidate the biological pathways affected by METTL25 deletion. Through the absence of this gene, researchers can observe changes in RNA methylation patterns, alterations in the transcriptome, and modifications in cellular responses to external stimuli. This knockout model allows for a more profound understanding of the molecular mechanisms underlying diseases where METTL25 might play a critical role, such as cancer and neurodegenerative disorders.
The scientific importance of METTL25 Gene Knockout Cell Lines extends into both basic research and clinical applications. They serve as invaluable assets for drug discovery, functional genomics, and therapeutic development. Their application in translational research can potentially lead to the identification of novel biomarkers and therapeutic targets, enhancing our ability to develop innovative treatment strategies.
Compared to other gene knockout models, METTL25 Gene Knockout Cell Lines offer enhanced specificity and reliability, thanks to the precision of contemporary CRISPR/Cas9 gene editing technologies employed in their creation. This specificity ensures that researchers can attribute observed phenotypic changes directly to METTL25 deletion without the confounding effects seen in less precise models.
For researchers and clinicians aiming to advance their understanding of gene function and its implications in various diseases, METTL25 Gene Knockout Cell Lines provide a unique and essential resource. Their ability to replicate in vivo-like conditions while allowing for controlled experimentation makes them an optimal choice for cutting-edge studies.
Our company prides itself on delivering high-quality biological products, backed by extensive research and development expertise. With a commitment to innovation and scientific rigor, we ensure that our offerings, such as the METTL25 Gene Knockout Cell Lines, meet the highest standards for advancing biological science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.